BLEVF - Beleave Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0351
-0.0039 (-10.00%)
At close: 1:56PM EDT
Stock chart is not supported by your current browser
Previous Close0.0390
Open0.0389
BidN/A x N/A
AskN/A x N/A
Day's Range0.0304 - 0.0440
52 Week Range0.0300 - 0.2500
Volume170,392
Avg. Volume94,143
Market Cap17.722M
Beta (3Y Monthly)3.52
PE Ratio (TTM)N/A
EPS (TTM)-0.0740
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Newsfile

    Beleave Announces Operational Updates and Q1 2019 Financials Release Date

    Toronto, Ontario--(Newsfile Corp. - September 19, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") today provides an update to its shareholders and prospective investors regarding the sale of the Lloydminster retail location, the London cultivation facility leaseback, the release date of its Q1 2019 financials, and the potential merger with Terrafarma Inc.Lloydminster Retail Sale UpdateAs previously disclosed on August 29, 2019, the Company is selling its retail location in Lloydminster, ...

  • Newsfile

    Beleave Provides Bi-Weekly Default Status Update

    Toronto, Ontario--(Newsfile Corp. - September 6, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") provides a status update on the management cease trade order (the "MCTO") which was granted by the Ontario Securities Commission (the "OSC") last month and the release of its Q1 2019 financials.As the result of a comprehensive interim review leading up to Beleave's Q4 2018 financials for the twelve months ended March 31, 2019, released on ...

  • Newsfile

    Beleave Announces LOI for Leaseback of London Production Facility and Sale of Lloydminster Retail Space

    Toronto, Ontario--(Newsfile Corp. - August 29, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce the signing of a letter of intent (the "LOI") on Tuesday, August 27, 2019, to negotiate, in good faith, with a private purchaser (the "Purchaser") to sell the Company's London, Ontario cultivation facility. Beleave will lease back 50 percent of the property after the sale is finalized to continue using the ...

  • Newsfile

    Beleave Provides Bi-Weekly Default Status Report

    Toronto, Ontario--(Newsfile Corp. - August 23, 2019) -  Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") hereby provides a status report on the management cease trade order ("MCTO"), announced in the Company's news release from August 8, 2019 (the "Default Announcement"), which was granted by the Ontario Securities Commission (the "OSC"), its principal regulator.Beleave is providing this bi-weekly default status report in accordance with National Policy 12-203 Management Cease Trade Orders ("NP ...

  • Newsfile

    Beleave's New Research License Allows for Further Optimization of Cannabinoids for Capsules and Edibles

    Toronto, Ontario--(Newsfile Corp. - August 13, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that on Friday, August 9, 2019, the Company's wholly-owned subsidiary Beleave Kannabis Corp was issued a Research License ("License") under the Cannabis Act and Cannabis Regulations of Canada. All research conducted under this License will be based on research protocols involving the further optimization and validation of methods for formulating cannabinoid compounds ...

  • Newsfile

    Beleave Announces Sale of Popular Blue Dream Strain

    Toronto, Ontario--(Newsfile Corp. - August 9, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that on July 31, 2019 the company commenced the sale of its Blue Dream strain to medical patients under the Beleave Kannabis Corp. medicinal brand. "Beleave is thrilled to be expanding its medicinal product offerings to include the extremely popular Blue Dream strain, which is available to medicinal patients in 5 ...

  • Newsfile

    Beleave Granted Management Cease Trade Order

    Toronto, Ontario--(Newsfile Corp. - August 8, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") announces that its principal regulator, the Ontario Securities Commission, has accepted the Company's application for, and has granted, a management cease trade order ("MCTO"). As previously announced on July 30, 2019, the application for the MCTO was made by the Company due to a delay in the filing of its audited annual financial statements. The Company ...

  • Newsfile

    Beleave Announces Non-Binding LOI with TerraFarma Inc.

    Toronto, Ontario--(Newsfile Corp. - August 7, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that the Company has entered into a non-binding letter of intent (the "LOI") that contemplates a business combination with TerraFarma Inc. ("TerraFarma").The precise structure of the transaction, including the exact exchange ratio of Beleave securities for TerraFarma securities has yet to be finalized. The parties have agreed to a thirty-day discussion ...

  • PR Newswire

    Beleave Announces Delay in Filing of Audited Financials

    TORONTO, July 30, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that it expects to file its audited annual financial statements and management's discussion and analysis for the twelve months ended March 31, 2019, which were required to be filed by July 29, 2019, in the next thirty days. The delay is due to a comprehensive internal audit currently underway, and a revisiting of the required financial guidelines relating to the review and analysis of previous results and statements by the Company. On June 28, 2019, the Company released restated financials for the nine months ending December 31, 2018 in response to guidelines and best practices imposed on the accounting practices for the cannabis industry in Canada as part of Beleave's ongoing commitment to transparency and clarity for the Company's stakeholders.

  • Newsfile

    Beleave Commences Sales of Cannabis Oils for the Canadian Adult Use Market

    First order shipped to Saskatchewan; purchase orders for other provinces and retailers imminent. Toronto, Ontario--(Newsfile Corp. - July 11, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") today announced that it has commenced sales of the Company's cannabis oils for the Canadian adult use market, with product expected to hit store shelves early next week."Adding oils to our product line allows us to meet the needs of our customers in ...

  • Newsfile

    Beleave Releases Restated Financials with 7% Revenue Increase for the Nine Months Ended December 31, 2018

    Toronto, Ontario--(Newsfile Corp. - June 28, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces today the release of its restated Condensed Interim Consolidated Financial Statements for three and nine months ended December 31, 2018, together with its Management, Discussion and Analysis ("MD&A").In October 2018, the guidelines and best-practices for issuers in the cannabis industry were updated with the intent of encouraging issuers to produce transparent information pertaining to financial ...

  • Newsfile

    Beleave Expands Recreational Cannabis Sales to Saskatchewan

    First Recreational Cannabis Shipment to Saskatchewan Marks Beleave's Expansion to Fourth Canadian Province Toronto, Ontario--(Newsfile Corp. - June 27, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has shipped its first order of recreational cannabis products for retail sale in the province of Saskatchewan.Beleave currently distributes recreational cannabis in three other Canadian provinces; British Columbia, Manitoba, and Ontario. The Company's current portfolio of products includes ...

  • Newsfile

    Beleave Receives Green Light for Building Permit as Hamilton Phase 2 Expansion Moves Forward

    Beleave will add almost 100,000 sq. ft.for cannabis extraction, processing, and cultivation. Phase 2 expects to generate approximately $50 million in annualized revenue with an average gross profit margin of 60 percent once fully operational. Toronto, Ontario--(Newsfile Corp. - June 24, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce today that it has received the required building permit from the City of Hamilton for its Hamilton Phase ...

  • PR Newswire

    Beleave Updates Prior Disclosure and Announces Approval of Settlement Agreement with the BCSC

    OTCQX: BLEVF) today announces a settlement with the British Columbia Securities Commission ("BCSC"), and provides updates to certain prior disclosure regarding agreements entered into and shares issued by the Company during its fiscal year ended March 31, 2019. The Company is pleased to announce that it has entered into a settlement agreement with Staff of the BCSC in connection with certain of the Company's historical disclosures, resolving the BCSC's review of Beleave's involvement in the BCSC's investigation relating to, among other things, the use of the consultant exemption from prospectus requirements (the "BCSC Matter").

  • OTC Markets Group Launches OTCQX Cannabis Index
    PR Newswire

    OTC Markets Group Launches OTCQX Cannabis Index

    NEW YORK , June 4, 2019 /PRNewswire/ --  OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...

  • Newsfile

    Beleave Expands Product Line with New Beleave-Branded Product Shipped to the OCS

    Beleave's San Fernando Valley marks the first Beleave-branded product marketed to the recreational market. Toronto, Ontario--(Newsfile Corp. - May 30, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has fulfilled its first shipment of a new Beleave-branded product line for the recreational market. The purchase order was placed by the Ontario Cannabis Store ("OCS").San Fernando Valley, the initial strain to be sold under the new ...

  • Newsfile

    Beleave Receives Approval for Hamilton Facility Expansion from City Council

    Beleave will add roughly 100,000 sq. ft. for cannabis extraction, processing, and cultivation. Toronto, Ontario--(Newsfile Corp. - May 23, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is ready to move forward with the long-awaited expansion of its Hamilton facility after receiving approval from the Hamilton City Council.Last Tuesday, the Planning Committee unanimously authorized Beleave's request to rezone the Hamilton facility and allowed the application to proceed forward to last ...

  • PR Newswire

    Beleave Receives Unanimous Approval from Hamilton Planning Committee

    TORONTO, May 15, 2019 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its meeting with the Hamilton Planning Committee on May 14, 2019. The committee unanimously approved Beleave's request to rezone their facility in Hamilton, Ontario and will reconvene later this month, through a city council meeting the week of May 20, 2019, to finalize the approval for expansion. Beleave's Hamilton facility continues to provide high-efficiency extraction, R&D, product development and cultivation of cannabis and cannabis derived products throughout this approval process.

  • CNW Group

    Beleave's Hamilton Expansion Set for Consideration by Planning Committee on May 14

    TORONTO , May 7, 2019 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that the Hamilton Planning Committee will consider the Company's upcoming Hamilton facility expansion plans during a public meeting to be held on May 14, 2019 . The Hamilton facility houses growing space for Beleave's line of cannabis products, and continues to be its main hub for extraction, packaging, and distribution.